Enliven Therapeutics Inc. (ELVN) Stock Holdings & Institutional Ownership

Enliven Therapeutics Inc.

ELVN

Super Fund	Position	Shares	Curr. Value	Port. %	Activity
Blackstone	Equity	1,320,592	$27,032,518	0.12%	0%
Duquesne Family Office	Equity	947,405	$19,393,000	0.49%	+104.62%

Total Shares Held: 2,267,997

Total Value Reported: $46,425,518

Average Allocation per Portfolio 0.30%

Largest Single Portfolio Allocation: 0.49%

Largest Shareholder: Blackstone

Change in Total Shares Held (Q on Q): +484,405

Percentage Change in Shares Held (Q on Q): 27.16%

Number of Current Holders: 2

Number of New Holders (Q on Q): 0

Number of Funds with Additions (Q on Q): 1

Number of Funds with Reductions (Q on Q): 0

Number of Funds Fully Divested (Q on Q): 0

Number of Funds with No Change (Q on Q): 1